Safety, feasibility of intravenous and intrathecal injection of autologous bone marrow derived mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: an open label phase I clinical trial. Cell J. 2019; 20 (4): 592-598. doi: 10.22074/cellj. 2019.5370

作者: SM Nabavi , L Arab , N Jarooghi , T Bolurieh , F Abbasi

DOI:

关键词:

摘要: Objective: Amyotrophic lateral sclerosis (ALS) is the most severe disorder within the spectrum of motor neuron diseases

参考文章(0)